Myriad Genetics Inc (NASDAQ:MYGN)

34.47
Delayed Data
As of May 21
 +0.02 / +0.06%
Today’s Change
31.56
Today|||52-Week Range
40.50
+1.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues188.8M168.8M184.4M180.0M
 
 
 
 
 
Cost of Goods Sold25.5M32.0M31.8M36.3M
 
 
 
 
 
Depreciation And Amortization5.5M6.0M6.0M--
 
 
 
 
 
Operating ExpensesGross Income157.8M130.9M146.5M143.7M
 
 
 
 
 
General Expenses104.5M105.0M110.2M108.0M
 
 
 
 
 
Research And Development20.2M22.6M17.5M16.7M
 
 
 
 
 
Total Operating Expenses135.5M142.9M148.1M144.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income53.3M25.9M36.3M35.7M
 
 
 
 
 
Other Expenses-908.0K-98.0K1.5M-298.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income52.6M25.9M37.9M35.6M
 
 
 
 
 
Income Taxes-18.9M-9.9M-13.9M-14.1M
 
 
 
 
 
Net Income33.6M16.0M24.0M21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.4M72.8M72.5M70.7M
 
 
 
 
 
Shares To Calculate EPS Diluted77.7M76.1M75.4M73.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.43$0.21$0.32$0.29
 
 
 
 
 
EPS Diluted$0.43$0.21$0.32$0.29
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account